Literature DB >> 12118756

Xenotransplant cardiac chimera: immune tolerance of adult stem cells.

Takayuki Saito1, Jin-Qiang Kuang, Bindu Bittira, Abdulaziz Al-Khaldi, Ray C J Chiu.   

Abstract

BACKGROUND: Bone marrow stromal cells have been shown to engraft into xenogeneic fetal recipients. In view of the potential clinical utility as an alternative source for cellular and gene therapies, we studied the fate of xenogeneic marrow stromal cells after their systemic transplantation into fully immunocompetent adult recipients without immunosuppression.
METHODS: Bone marrow stromal cells were isolated from C57B1/6 mice and retrovirally transduced with LacZ reporter gene for cell labeling. We then injected 6 x 10(6) labeled cells into immunocompetent adult Lewis rats. One week later, the recipient animals underwent coronary artery ligation and were sacrificed at various time points ranging from 1 day to 12 weeks after ligation. Hearts, blood, and bone marrow samples were collected for histologic and immunohistochemical studies.
RESULTS: Labeled mice cells engrafted into the bone marrow cavities of the recipient rats for at least 13 weeks after transplantation without any immunosuppression. On the other hand, circulating mice cells were positive only for the animals with 1-day-old myocardial infarction. At various time points, numerous mice cells could be found in the infarcted myocardium that were not seen before coronary ligation. Some of these cells subsequently showed positive staining for cardiomyocyte specific proteins, while other labeled cells participated in angiogenesis in the infarcted area.
CONCLUSIONS: The marrow stromal cells are adult stem cells with unique immunologic tolerance allowing their engraftment into a xenogeneic environment, while preserving their ability to be recruited to an injured myocardium by way of the bloodstream and to undergo differentiation to form a stable cardiac chimera.

Entities:  

Mesh:

Year:  2002        PMID: 12118756     DOI: 10.1016/s0003-4975(02)03591-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  58 in total

1.  Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma.

Authors:  Jeffrey L Spees; Scott D Olson; Joni Ylostalo; Patrick J Lynch; Jason Smith; Anthony Perry; Alexandra Peister; Meng Yu Wang; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

Review 2.  Bone-marrow stem cells as a source for cell therapy.

Authors:  Ray C-J Chiu
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

3.  Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution.

Authors:  Zhina Sadeghi; Justin Isariyawongse; Michael Kavran; Kenan Izgi; Gabriela Marini; Joseph Molter; Firouz Daneshgari; Chris A Flask; Arnold Caplan; Adonis Hijaz
Journal:  Int Urogynecol J       Date:  2015-09-09       Impact factor: 2.894

4.  Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Authors:  Na Li; Yue-Jin Yang; Hai-Yan Qian; Qing Li; Qian Zhang; Xiang-Dong Li; Qiu-Ting Dong; Hui Xu; Lei Song; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 5.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

6.  Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Jin Kyung Lee; Eun-Young Park; Eun-Ae Park; K Daniel Riew; Seung-Koo Rhee
Journal:  Eur Spine J       Date:  2008-09-25       Impact factor: 3.134

7.  Immunological properties of embryonic and adult stem cells.

Authors:  Francesco Bifari; Luciano Pacelli; Mauro Krampera
Journal:  World J Stem Cells       Date:  2010-06-26       Impact factor: 5.326

8.  Ultrasound-mediated microbubble destruction enhances the therapeutic effect of intracoronary transplantation of bone marrow stem cells on myocardial infarction.

Authors:  Xuefeng Chang; Jiaqing Liu; Xudong Liao; Guohui Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 9.  Paving the way towards universal treatment with allogenic T cells.

Authors:  Michelle H Townsend; Kelsey Bennion; Richard A Robison; Kim L O'Neill
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

10.  Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.

Authors:  Ting C Zhao; Andy Tseng; Naohiro Yano; Yitang Tseng; Pamela A Davol; Randall J Lee; Lawrence G Lum; James F Padbury
Journal:  J Appl Physiol (1985)       Date:  2008-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.